Clinical Trial Update: Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial report on ATH3G10 for patients with ST-elevation myocardial infarction evaluating efficacy, safety, and tolerability has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• ATH3G10

Snippet

Sponsor: Athera Biotechnologies AB | Conditions: ST Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED